Blastocystis is associated with decrease of fecal microbiota protective bacteria: Comparative analysis between patients with irritable bowel syndrome and control subjects

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Nourrisson, Celine ^a,b,c   Scanzi, Julien ^b,d   Pereira, Bruno ^d   NkoudMongo, Christina ^a   Wawrzyniak, Ivan ^b,c   Cian, Amandine ^e   Viscogliosi, Eric ^e   Livrelli, Valérie ^a,b   Delbac, Frédéric ^b,c   Dapoigny, Michel ^b,d   Poirier, Philippe ^a,b,c  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITÉ BLAISE PASCAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BLASTOCYSTIS; BLASTOCYSTOSIS; CHRONIC DISEASE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DESULFOVIBRIO; DIARRHEA; DIENTAMOEBA; DNA EXTRACTION; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL DISEASE; GENE SEQUENCE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MICROBIAL COMMUNITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW; ADULT; AGED; FECES; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PARASITOLOGY;

BLASTOCYSTIS;

ADULT; AGED; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MICROBIOTA; MIDDLE AGED;

EID: 84909619811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111868     Document Type: Article

References (57)

1. Tan KSW (2008) New Insights on Classification, Identification, and Clinical Relevance of Blastocystis spp. Clin Microbiol Rev 21: 639-665. doi:10.1128/ CMR.00022-08.
2. Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ESU, Fagbenro-Beyioku AF, et al. (2013) Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop 126: 11-18. doi:10.1016/ j.actatropica.2012.12.011.
3. El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, et al. (2014) Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 14: 164. doi:10.1186/1471-2334-14-164.
4. Poirier P, Wawrzyniak I, Vivarès CP, Delbac F, El Alaoui H (2012) New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog 8: e1002545. doi:10.1371/journal.ppat.1002545.
5. Dapoigny M (2009) Irritable bowel syndrome: epidemiology/economic burden. Gastroentérologie Clin Biol 33 Suppl 1: S3-8. doi:10.1016/S0399-8320(09)71519-2.
6. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480-1491. doi:10.1053/j.gastro.2005.11.061.
7. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, et al. (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56: 1770-1798. doi:10.1136/gut.2007.119446.
8. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, et al. (2009) Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58: 196-201. doi:10.1136/ gut.2007.140806.
9. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, et al. (2002) Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122: 1778-1783.
10. Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, et al. (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141: 1792-1801. doi:10.1053/j.gastro.2011.07.043.
11. Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, et al. (2009) Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58: 751-761. doi:10.1136/gut.2007.144543.
12. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK (2010) Host-bacterial symbiosis in health and disease. Adv Immunol 107: 243-274. doi:10.1016/ B978-0-12-381300-8.00008-3.
13. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174-180. doi:10.1038/ nature09944.
14. Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, et al. (2013) The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 25: e272-282. doi:10.1111/nmo.12103.
15. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220-230. doi:10.1038/nature11550.
16. Malinen E, Rinttilä T, Kajander K, Mä ttö J, Kassinen A, et al. (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100: 373-382. doi:10.1111/j.1572-0241.2005.40312.x.
17. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 24: 521-530, e248. doi:10.1111/j.1365-2982.2012.01891.x.
18. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736. doi:10.1073/pnas.0804812105.
19. Willing BP, Russell SL, Finlay BB (2011) Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9: 233-243. doi:10.1038/ nrmicro2536.
20. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G (1999) Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 18: 436-439.
21. Yakoob J, Jafri W, Jafri N, Khan R, Islam M, et al. (2004) Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 70: 383-385.
22. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, et al. (2010) Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 106: 1033-1038. doi:10.1007/s00436-010-1761-x.
23. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, et al. (2010) Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 107: 679-684. doi:10.1007/s00436-010-1918-7.
24. Dogruman-Al F, Kustimur S, Yoshikawa H, Tuncer C, Simsek Z, et al. (2009) Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz 104: 724-727.
25. Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, et al. (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110: 1269-1275. doi:10.1007/s00436-011-2626-7.
26. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, et al. (2004) Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 35: 705-710.
27. Thamrongwittawatpong L, Surangsrirat S (2006) Assessment of the association between Blastocystis hominis infection and irritable bowel syndrome in Phramongkutklao Hospital. Thai J Gastroenterol.
28. Surangsrirat S, Thamrongwittawatpong L, Piyaniran W, Naaglor T, Khoprasert C, et al. (2010) Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thail Chotmaihet Thangphaet 93 Suppl 6: S119-124.
29. Ramírez-Miranda ME, Jiménez-González DE, Rodríguez-Campa ME, Gonzá-lez-Angulo A, Hernández-Castellanos R, et al. (2011) Irritable Bowel Syndrome: Frequency and phylogenetic relationship of Blastocystis sp. from Mexican patients. Rev Gastroenterol México 76: 309-315.
30. Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar FG, et al. (2012) Blastocystosis in patients with gastrointestinal symptoms: a case-control study. BMC Gastroenterol 12: 122. doi:10.1186/1471-230X-12-122.
31. Barratt JLN, Harkness J, Marriott D, Ellis JT, Stark D (2011) A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2: 3-12. doi:10.4161/gmic.2.1.14755.
32. Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P (2012) Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 87: 1046-1052. doi:10.4269/ajtmh.2012.11-0761.
33. Pérez PF, Minnaard J, Rouvet M, Knabenhans C, Brassart D, et al. (2001) Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study. Appl Environ Microbiol 67: 5037-5042. doi:10.1128/ AEM.67.11.5037-5042.2001.
34. Galván-Moroyoqui JM, Del Carmen Domínguez-Robles M, Franco E, Meza I (2008) The interplay between Entamoeba and enteropathogenic bacteria modulates epithelial cell damage. PLoS Negl Trop Dis 2: e266. doi:10.1371/ journal.pntd.0000266.
35. Scanlan PD, Stensvold CR (2013) Blastocystis: getting to grips with our guileful guest. Trends Parasitol 29: 523-529. doi:10.1016/j.pt.2013.08.006.
36. Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, et al. (2011) Development and evaluation of a real-time PCR assay for detection and quantification of Blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol 49: 975-983. doi:10.1128/JCM.01392-10.
37. Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2006) Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens. J Clin Microbiol 44: 232-235. doi:10.1128/ JCM.44.1.232-235.2006.
38. Lovell RM, Ford AC (2012) Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 107: 991-1000. doi:10.1038/ajg.2012.131.
39. Heitkemper M, Jarrett M (2008) Irritable bowel syndrome: does gender matter? J Psychosom Res 64: 583-587. doi:10.1016/j.jpsychores.2008.02.020.
40. Domínguez-Márquez MV, Guna R, Muñoz C, Gómez-Muñoz MT, Borrás R (2009) High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain). Parasitol Res 105: 949-955. doi:10.1007/s00436-009-1485-y.
41. Stark DJ, Beebe N, Marriott D, Ellis JT, Harkness J (2006) Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 22: 92-96. doi:10.1016/j.pt.2005.12.001.
42. Cremon C, Carini G, De Giorgio R, Stanghellini V, Corinaldesi R, et al. (2010) Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon? Expert Rev Mol Diagn 10: 389-393. doi:10.1586/erm.10.33.
43. Simrén M, Barbara G, Flint HJ, Spiegel BMR, Spiller RC, et al. (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62: 159-176. doi:10.1136/gutjnl-2012-302167.
44. Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, et al. (2012) Functional dysbiosis within the gut microbiota of patients with constipatedirritable bowel syndrome. Aliment Pharmacol Ther 35: 828-838. doi:10.1111/ j.1365-2036.2012.05007.x.
45. Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69: 4320-4324.
46. Russell DA, Ross RP, Fitzgerald GF, Stanton C (2011) Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 149: 88-105. doi:10.1016/j.ijfoodmicro.2011.06.003.
47. Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, et al. (2014) Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes 5: 146-151. doi:10.4161/gmic.27651.
48. Denoeud F, Roussel M, Noel B, Wawrzyniak I, Da Silva C, et al. (2011) Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol 12: R29. doi:10.1186/gb-2011-12-3-r29.
49. Park SR, Han AR, Ban Y-H, Yoo YJ, Kim EJ, et al. (2010) Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects. Appl Microbiol Biotechnol 85: 1227-1239. doi:10.1007/s00253-009-2326-8.
50. Verma AK, Verma R, Ahuja V, Paul J (2012) Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India. BMC Microbiol 12: 183. doi:10.1186/1471-2180-12-183.
51. Poirier P, Meloni D, Nourrisson C, Wawrzyniak I, Viscogliosi E, et al. (2014) Molecular subtyping of Blastocystis spp. using a new rDNA marker from the mitochondria-like organelle genome. Parasitology 141: 670-681. doi:10.1017/ S0031182013001996.
52. Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, et al. (2004) Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53: 523-529.
53. Gueimonde M, Tölkkö S, Korpimäki T, Salminen S (2004) New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol 70: 4165-4169. doi:10.1128/AEM.70.7.4165-4169.2004.
54. Bartosch S, Fite A, Macfarlane GT, McMurdo MET (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70: 3575-3581. doi:10.1128/ AEM.70.6.3575-3581.2004.
55. Furet J-P, Firmesse O, Gourmelon M, Bridonneau C, Tap J, et al. (2009) Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68: 351-362. doi:10.1111/ j.1574-6941.2009.00671.x.
56. Lopez-Siles M, Martinez-Medina M, Busquets D, Sabat-Mir M, Duncan SH, et al. (2014) Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. Int J Med Microbiol IJMM 304: 464-475. doi:10.1016/j.ijmm.2014.02.009.
57. Borenstein M, Hedges L, Higgins J, Rothstein H (2005) Comprehensive Meta-Analysis Version 2. Engelwood, NJ., Biostat.